Clinical Trial Update: Celecoxib Treatment for Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of celecoxib for non-small cell lung cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Non-Small-Cell Lung Carcinoma | Phase 1 | Status: WITHDRAWN